← All stocks

Aptevo Therapeutics Inc.

APVO Net buying
CIK 0001671584 #5433 in the set updated 21 Sep 2026
Bought (12 mo)
$20.13K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$20.13K
+$20.13K against sales at will

By person

10 insiders · 1 transaction
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Grant Grady III
Director
$20.13K (1)
+$20.13K
1,150
$1.71K
White Marvin L
Executive Chair
1,261
$1.88K
Lamothe Jeffrey G.
President and CEO
967
$1.44K
Taylor Daphne
SVP, CFO
638
$950.62
Kwon SoYoung
SVP, GC, BD & Corp Affairs
638
$950.62
Huebner Dirk
SVP, CMO
482
$718.18
Harsanyi Zsolt
Director
400
$596.00
Abdun-Nabi Daniel
Director
400
$596.00
Kunz Barbara Lopez
Director
400
$596.00
Niederhuber John
Director
400
$596.00

No percentages here. This company's share count has moved by a factor of 15.7 over the window, from 1,181,725 to 18,512,084 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 12
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 7,104
History held since 27 Sep 2016